Cite
HARVARD Citation
Petri, M. et al. (n.d.). THU0387 Effects of Blisibimod, An Inhibitor of B Cell Activating Factor, On Patient Reported Outcomes and Disease Activity in Patients with Systemic Lupus Erythematosus. Annals of the rheumatic diseases. pp. 336-337. [Online].